Proof of concept and dose estimation with binary responses under model uncertainty
Author:
- 14 November 2008
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 28 (2) , 274-292
Abstract
This article suggests a unified framework for testing Proof of Concept (PoC) and estimating a target dose for the benefit of a more comprehensive, robust and powerful analysis in phase II or similar clinical trials. From a pre‐specified set of candidate models, we choose the ones that best describe the observed dose–response. To decide which models, if any, significantly pick up a dose effect, we construct the permutation distribution of the minimum P‐value over the candidate set. This allows us to find critical values and multiplicity adjusted P‐values that control the familywise error rate of declaring any spurious effect in the candidate set as significant. Model averaging is then used to estimate a target dose. Popular single or multiple contrast tests for PoC, such as the Cochran–Armitage, Dunnett or Williams tests, are only optimal for specific dose–response shapes and do not provide target dose estimates with confidence limits. A thorough evaluation and comparison of our approach to these tests reveal that its power is as good or better in detecting a dose–response under various shapes with many more additional benefits: It incorporates model uncertainty in PoC decisions and target dose estimation, yields confidence intervals for target dose estimates and extends to more complicated data structures. We illustrate our method with the analysis of a Phase II clinical trial. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Model Averaging Using Fractional Polynomials to Estimate a Safe Level of ExposureRisk Analysis, 2007
- Estimating the predictive quality of dose–response after model selectionStatistics in Medicine, 2007
- Design and Analysis of Dose-Finding Studies Combining Multiple Comparisons and Modeling ProceduresJournal of Biopharmaceutical Statistics, 2006
- Bayesian Model Averaging With Applications to Benchmark Dose Estimation for Arsenic in Drinking WaterJournal of the American Statistical Association, 2006
- Model Averaging Using the Kullback Information Criterion in Estimating Effective Doses for Microbial Infection and IllnessRisk Analysis, 2005
- Frequentist Model Average EstimatorsJournal of the American Statistical Association, 2003
- Detecting dose-response using contrasts: asymptotic power and sample size determination for binomial dataStatistics in Medicine, 2002
- Model Selection: An Integral Part of Inference1997
- Tests for Differences Between Several Small ProportionsJournal of the Royal Statistical Society Series C: Applied Statistics, 1988
- On the Robustness of Combined Tests for Trends in ProportionsJournal of the American Statistical Association, 1980